OPTUS
"OPTUS" is a word and design mark owned by OPTUS Pharmaceutical CO., LTD., filed at the USPTO on May 26, 2022. It is in its opposition period and covers classes 5, 10 and 35.
- Status
- Opposition period
- Since April 15, 2024
- Filed
- May 26, 2022
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 79346026
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 3 classes
Who owns OPTUS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
OPTUS Pharmaceutical CO., LTD.
South Korea
Representative
Seong Il Jeong
Korus Patent, LLC
What the mark covers
The products and services OPTUS is filed for, grouped by Nice class.
Eye drops; artificial tears; cleaning solutions for contact lenses; contact lens cleaning preparations; contact lens disinfectants; contact lens wetting solutions; solutions for contact lenses; pharmaceuticals, namely, anti-infectives; medicated preparations for skin treatment, namely, medicated serums for treatment of skin; antipyretic analgesics; vaginal washes for medical purposes; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases; cardiovascular pharmaceutical preparations; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for use as a dietary supplement; medical and surgical plasters; biological tissue cultures for medical purposes; food for babies; pharmaceutical products for the treatment of infectious diseases
Eye droppers for medical purposes; electrically heated massaging apparatus for household purposes; portable electric massaging apparatus; sanitary masks for medical purposes; protective facial masks for medical purposes; gloves for medical purposes; contraceptive apparatus
Promoting the goods and services of others by means of operating an on-line shopping mall with links to the retail web sites of others; business intermediary services relating to mail order by telecommunications, namely, mediation of agreements regarding the sale and purchase of goods via mail order; retail store services featuring medicines for eye diseases; wholesale distributorships services featuring medicines for eye diseases; commercial intermediary services in the field of medicines for eye diseases, namely, mediation of agreements regarding the sale and purchase of goods in the field of medicines for eye diseases; retail store services featuring nutritional supplements for therapeutic or medical use; wholesale distributorships services featuring nutritional supplements for therapeutic or medical use; commercial intermediary services in the field of health functional food for treatment or medical use, namely, mediation of agreements regarding the sale and purchase of goods in the field of health functional food for treatment or medical use; demonstration of goods for advertising purposes; advertising and commercial information services; publicity and sales promotion services; import and export agencies; retail store services featuring pharmaceutical products for medical purposes; wholesale distributorships services featuring pharmaceutical products for medical purposes; commercial intermediary services in the field of pharmaceutical products, namely, mediation of agreements regarding the sale and purchase of goods in the field of pharmaceutical products for medical purposes; arranging of contracts for the sale of pharmaceuticals products, namely, mediation of agreements regarding the sale and purchase of goods in the field of pharmaceutical products for medical purposes; outsourcing services in the nature of arranging procurement of goods for other businesses in the nature of pharmaceutical products; auction and reverse auction services
What has happened so far
Steps recorded by the USPTO, newest first.
- Limitation from the ib examined, no action is needed
- Attorney review completed
- Limitation of goods received from ib
- Limitation from the ib - request exam review
- Limitation of goods received from ib
- Refusal processed by ib
- Opposition instituted no. 999999
- Opposition papers received at ttab
- Extension of time to oppose process - terminated
- Opposition notice (ib refusal) sent to ib
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About OPTUS
Who owns the trademark "OPTUS"?
The USPTO trademark "OPTUS" (application 79346026) is owned by OPTUS Pharmaceutical CO., LTD.
What is the status of "OPTUS"?
Its status at the USPTO is: opposition period.
Get this data via the API
Everything on this page comes from the Signa API. Pull OPTUS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b18-fe55-77ee-b67e-5717e2380df1
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b18-fe55-77ee-b67e-5717e2380df1",
"object": "trademark",
"mark_text": "OPTUS",
"status": {
"primary": "pending",
"stage": "pending_opposition"
},
"office_code": "US",
"application_number": "79346026",
"filing_date": "2022-05-26",
"nice_classes": [
5,
10,
35
],
"owners": [
{
"name": "OPTUS Pharmaceutical CO., LTD.",
"entity_id": "ent_019ebb74-177c-77ad-a7e7-b00e458df157"
}
]
}